Open AccessModeling Dendritic Cell Vaccination for Influenza Prophylaxis: Potential Applications for Niche Populations
Author(s) -
Vanaja Konduri,
William K. Decker,
Matthew M. Halpert,
Brian E. Gilbert,
Amar Safdar
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit087
Subject(s) - vaccination , elispot , immunology , dendritic cell , virology , biology , virus , immunotherapy , antibody titer , antigen , medicine , t cell , titer , immune system
Cancer patients can exhibit negligible responses to prophylactic vaccinations, including influenza vaccination. To help address this issue, we developed in vitro and in vivo models of dendritic cell (DC) immunotherapy for the prevention of influenza virus infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom